Clinical Trials Sponsored by Shanghai Chest Hospital

Total 3171 results

Shanghai Chest Hospital
Changhai Hospital; Ruijin Hospital

Unknown

Chemotherapy Plus Gefitinib for Advanced Lung Adenocarcinoma and Sensitive EGFR Mutations: a Randomized Controlled Trial

Lung Adenocarcinoma
Shanghai Chest Hospital

Recruiting

Prediction of Anastomotic Complications and Recurrent Laryngeal Nerve Injury Based on Postoperative Early Endoscopic Evaluation

Anastomotic Leak | Esophageal Neoplasm | Anastomotic Stenosis | Recurrent Laryngeal Nerve Injuries | Endoscopic Evaluation

China
Shanghai Chest Hospital

Not yet recruiting

Neoadjuvant Adebrelimab Plus Chemotherapy for Resectable ESCC: a Single Arm, Prospective Phase 2 Clinical Trial

Esophageal Squamous Cell Carcinoma

China
Shanghai Chest Hospital

Not yet recruiting

RAE Versus MIE in Patients With Esophageal Cancer After Neoadjuvant Therapy

Surgical Procedure, Unspecified

China
Shanghai Chest Hospital

Recruiting

Molecular Analysis and Treatment Options of SCLC

Small Cell Lung Carcinoma | Small-cell Lung Cancer | Small Cell Lung Cancer Limited Stage | Small Cell Lung Cancer Extensive Stage | Small Cell Lung Cancer, Combined Type

China
Shanghai Chest Hospital

Recruiting

Molecular Landscape Analysis and Clinical Implications for NSCLC Patients With Rare Mutations

NSCLC | NSCLC Stage IV | NSCLC, Recurrent

China
Shanghai Chest Hospital

Recruiting

Molecular Analysis and Treatment Options of Thymic Malignancies

Thymic Carcinoma | Thymic Epithelial Tumor | Thymic Cancer

China
Shanghai Chest Hospital

Not yet recruiting

Salvage Immunotherapy and Chemotherapy in Esophageal Squamous Cell Carcinoma Patients Nonresponding to Initial Neoadjuvant Chemoradiotherapy (SINCERE)

Esophageal Squamous Cell Carcinomas
Shanghai Chest Hospital

Recruiting

ENB-guided Ablation Therapy Combined With VATS in the Treatment of MPLC

Lung Cancer

China
Shanghai Chest Hospital

Recruiting

China Lung Cancer Screening (CLUS) Study Version 2.0

Lung Neoplasms

China
Shanghai Chest Hospital

Active, not recruiting

To Evaluate the Efficacy of Durvalumab + Anlotinib in Terms of OS and PFS.

Extensive-Stage Small-Cell Lung Cancer

China
Shanghai Chest Hospital

Completed

The Chinese Registration Study of Driver Ablation of Persistent Atrial Fibrillation.

Atrial Fibrillation, Persistent

China
Shanghai Chest Hospital

Unknown

To Evaluate the Role of Postoperative Radiotherapy in Patients With IIIA(N2) Non-Small Cell Lung Cancer

Radiotherapy | Non-small Cell Lung Cancer Stage IIIA

China
Shanghai Chest Hospital

Unknown

Prediction Model of Peripheral Pulmonary Lesions Based on R-EBUS Image (R-EBUS)

Diagnoses Disease

China
Shanghai Chest Hospital

Unknown

Transbronchial Ablation for Peripheral Lung Tumor

Lung Cancer

China
Shanghai Chest Hospital

Unknown

ENB Guided MWA for Early-stage Peripheral Lung Cancer

Lung Cancer

China
Shanghai Chest Hospital

Unknown

Clinical Study of ctDNA and Exosome Combined Detection to Identify Benign and Malignant Pulmonary Nodules (ctDNA)

Pulmonary Nodules

China
Shanghai Chest Hospital

Unknown

First-line Combination Treatment Based on Anlotinib

Lung Cancer | Advanced Stage

China
Shanghai Chest Hospital

Unknown

EBUS Image Features in the Diagnosis of PPLs

Endobronchial Ultrasound
Shanghai Chest Hospital

Completed

The Safety and Efficacy of Tolvaptan for Patients With Tricuspid Regurgitation and Right Heart Failure After Left Heart Valves Replacement

Right Heart Failure | Tricuspid Regurgitation

China
Shanghai Chest Hospital

Unknown

Optimization for the Treatment of Advanced Pulmonary Large Cell Neuroendocrine Carcinoma

Pulmonary Large Cell Neuroendocrine Carcinoma
Shanghai Chest Hospital

Unknown

18F-FDG Metabolism Imaging Monitoring Non-small Cell Lung Cancer Curative Effect of Chemotherapy Multicenter Clinical Study

Non-small-cell Lung Cancer
Shanghai Chest Hospital

Unknown

Early Stage Lung Cancer Screening With Low-dose Computed Tomographic

Lung Cancer

China
Shanghai Chest Hospital

Unknown

Recombinant BNP on Heart and Renal Function in Acute Heart Failure

Acute Renal Failure | Acute Heart Failure

China
Shanghai Chest Hospital

Recruiting

Immunotherapy in Combination With Chemoradiotherapy in Unresectable Locally Advanced Esophageal Cancer

Esophageal Squamous Cell Carcinoma | Unresectable Locally Advanced Esophageal Cancer

China
Shanghai Chest Hospital

Not yet recruiting

A Multi-center RCT to Evaluate Subsegmental BTVA Treatment for Severe Emphysema (BTVA)

Severe Emphysema
Shanghai Chest Hospital

Recruiting

Radiotherapy Combined With Immunochemotherapy in Metastatic Esophageal Squamous Cell Carcinoma

Esophageal Cancer | Esophageal Squamous Cell Carcinoma | Metastatic Esophageal Squamous Cell Carcinoma

China
Shanghai Chest Hospital

Not yet recruiting

A Randomized Controlled Study of Ablation Pursuing Atrial Fibrillation Termination as a Procedural Endpoint in Patients With Persistent Atrial Fibrillation

Atrial Fibrillation | Cathter Ablation | Endpoint

China
Shanghai Chest Hospital

Recruiting

Application of Mixed Reality Technique for Percutaneous Lung Nodule Localization: A Prospective, Randomized, Controlled Trial (MR)

Lung Cancer

China
Shanghai Chest Hospital

Not yet recruiting

Chemoradiotherapy Following Immunotherapy Plus Chemotherapy for Locally-advanced Esophageal Squamous Cell Cancer (RICE) (RICE)

Chemotherapy | Immunotherapy | Concurrent Chemoradiotherapy | Esophageal Squamous Cell Carcinomas
Shanghai Chest Hospital

Not yet recruiting

Electroacupuncture Intervention in Catheter Ablation of Atrial Fibrillation

Atrial Fibrillation | Catheter Ablation
Shanghai Chest Hospital

Recruiting

mCBCT in Combination With ENB for the Diagnosis of PPNs

Lung Cancer | Peripheral Pulmonary Nodules

China
Shanghai Chest Hospital

Recruiting

China Lung Cancer Screening (CLUS) Study Version 3.0

Lung Cancer

China
Shanghai Chest Hospital

Recruiting

First-line Treatment With Dacomitinib Plus Anlotinib for Patients With Advanced NSCLC With EGFR 21L858R Mutations

Non-Small Cell Lung Cancer (NSCLC)

China
Shanghai Chest Hospital

Not yet recruiting

SHR-1701 for Consolidation Therapy After Concurrent Chemoradiotherapy in Inoperable Stage III NSCLC

NSCLC, Stage III
Shanghai Chest Hospital

Not yet recruiting

Left Atrial Isolation by Catheter Ablation in Persistent Atrial Fibrillation With Severe Atrial Fibrosis

Persistent Atrial Fibrillation
Shanghai Chest Hospital

Not yet recruiting

Augmented Reality-assisted Localization of Solitary Pulmonary Nodules for Precise Sublobar Lung Resection (ARPL)

Lung Cancer | SPN
Shanghai Chest Hospital

Not yet recruiting

Catgut Embedding in Acupoints on Treating Persistent Atrial Fibrillation After Catheter Ablation

Persistent Atrial Fibrillation
Shanghai Chest Hospital

Not yet recruiting

Anlotinib Combined With PD-1 Inhibitors for Advanced/Metastatic Esophageal Cancer (APEC)

Esophageal Cancer
Shanghai Chest Hospital

Recruiting

Analysis of Drug Resistance in Immune Checkpoint Inhibitors of Non-small Cell Lung Cancer

Non-Small Cell Lung Cancer

China
Shanghai Chest Hospital

Recruiting

Advanced Lung Tumor Treated by Osimertinib Plus Anlotinib (AUTOMAN)

Metastatic Cancer | Adenocarcinoma of Lung | Non-Small Cell Lung Cancer With EGFR Mutation | Locally Advanced Solid Tumor

China
Shanghai Chest Hospital

Recruiting

NGS-based Comprehensive Genomic ctDNA Panel in NSCLC With Immunotherapy

Lung Cancer

China
Shanghai Chest Hospital

Recruiting

Dacomitinib in Lung Cancer With Uncommon EGFR Mutations

Non-small Cell Lung Cancer Metastatic | EGF-R Positive Non-Small Cell Lung Cancer

China
Shanghai Chest Hospital

Not yet recruiting

Cardiac Adverse Reactions Related to Immune Checkpoint Inhibitor in NSCLC Patients

Cardiac Event | Immune Checkpoint Inhibitor | Adverse Reactions | Non-Small Cell Lung Cancer Patients
Shanghai Chest Hospital

Recruiting

Neoadjuvant Therapy in Resectable Non-Small Cell Lung Cancer Stages IIB-IIIB

Non Small Cell Lung Cancer

China
Shanghai Chest Hospital

Recruiting

Comparison of Esophagectomy and Chemoradiation for Patients With cN0-pT1b Stage Esophageal Squamous Cell Carcinoma

Esophageal Cancer

China
Shanghai Chest Hospital

Recruiting

Accelerated Hypofractionated vs. Conventionally Fractionated Concurrent CRT for LS-SCLC

SCLC

China
Shanghai Chest Hospital

Unknown

cfDNA Methylation Assay for Clinical Evaluation of Patients With Stage IA Lung Cancer After Ablation Operation

Lung Cancer

China
Shanghai Chest Hospital

Unknown

Prediction Model of CP-EBUS in the Diagnosis of Lymph Nodes

Lymph Node Disease

China
Shanghai Chest Hospital

Unknown

NGS-based Large-panel in Targeted Drug Delivery and Immunotherapy of Lung Cancer

Lung Neoplasms

China

3

Subscribe